Form 4 for PTGX Protagonist Therapeutics, Inc
Accepted 2025-03-14 00:00:00 ET · period of report 2025-03-13 · accession 0001104659-25-024063 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-14 | 2025-03-13 | PTGX | MOLINA ARTURO MD | Chief Medical Off | M - OptEx | $24.48 | +30.5K | 112.3K | +37% | +$747.0K |
| D | 2025-03-14 | 2025-03-13 | PTGX | MOLINA ARTURO MD | Chief Medical Off | S - Sale+OE | $55.74 | -30.5K | 83.9K | -27% | -$1.70M |
| DM | 2025-03-14 | 2025-03-13 | PTGX | MOLINA ARTURO MD | Chief Medical Off | M - OptEx | $0.00 | -30.5K | 47.8K | -39% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-13 | M | A | 2,077 | $38.98 | 114,406 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-13 | S | D | 30,514 | $55.74 | 83,892 | D | — | — | (F1) The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $55.245 to $56.06. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2025-03-13 | M | A | 28,437 | $23.42 | 112,329 | D | — | — | |
| 4 | Derivative | Stock Option (right to buy) | 2025-03-13 | M | D | 28,437 | $0.00 | 69,063 | D | $23.42 · — to 2034-01-02 | 28,437 Common Stock | (F2) The stock option vests in 48 equal monthly installments following January 2, 2024, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. |
| 5 | Derivative | Stock Option (right to buy) | 2025-03-13 | M | D | 2,077 | $0.00 | 47,785 | D | $38.98 · — to 2035-01-02 | 2,077 Common Stock | (F3) The stock option vests in 48 equal monthly installments following January 2, 2025, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. |